Jump Financial’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.1M Sell
44,202
-60,400
-58% -$1.56M 0.02% 886
2025
Q4
$2.66M Sell
104,602
-191,658
-65% -$4.27M 0.03% 574
2025
Q3
$4.78M Sell
296,260
-26,586
-8% -$430K 0.06% 423
2025
Q2
$5.17M Buy
322,846
+122,011
+61% +$1.85M 0.06% 406
2025
Q1
$3.43M Buy
200,835
+71,167
+55% +$1.49M 0.05% 425
2024
Q4
$3.21M Buy
129,668
+68,312
+111% +$1.94M 0.07% 372
2024
Q3
$1.75M Sell
61,356
-90,116
-59% -$2.66M 0.04% 576
2024
Q2
$4M Buy
151,472
+56,472
+59% +$1.61M 0.08% 307
2024
Q1
$3.07M Buy
95,000
+65,928
+227% +$2.41M 0.08% 280
2023
Q4
$1.22M Buy
29,072
+17,046
+142% +$627K 0.04% 606
2023
Q3
$462K Buy
+12,026
New +$272K 0.02% 1068
2023
Q2
Sell
-45,600
Closed -$707K 1969
2023
Q1
$707K Buy
+45,600
New +$791K 0.03% 747
2022
Q2
Sell
-18,700
Closed -$103K 1805
2022
Q1
$103K Sell
18,700
-54,200
-74% -$338K ﹤0.01% 1404
2021
Q4
$621K Sell
72,900
-700
-1% -$5.78K 0.04% 561
2021
Q3
$640K Sell
73,600
-65,435
-47% -$590K 0.05% 416
2021
Q2
$1.47M Buy
139,035
+116,471
+516% +$1.63M 0.14% 182
2021
Q1
$361K Buy
22,564
+14,264
+172% +$376K 0.03% 531
2020
Q4
$383K Buy
+8,300
New +$384K 0.07% 484

Other funds holding IMVT